| Literature DB >> 10867147 |
P Temperani1, M Luppi, F Giacobbi, V Medici, M Morselli, P Barozzi, R Marasca, G Torelli, G Emilia.
Abstract
The late appearance of a cytogenetic/molecular hallmark in human leukemias is a rare event. We report on a case of acute myeloid leukemia with morphology, immunophenotype and clinical features typical of promyelocytic subtype (APL), in which the specific PML/RARalpha gene rearrangement was molecularly detected only at second relapse of disease, without cytogenetic evidence of the t(15;17). The emergence of the PML/RARalpha gene may be therapy-related or may represent the exceptional result of a clonal evolution during progression of neoplasia. At second relapse, a novel cell clone bearing a t(12;13)(p13.2;q14) was also observed and a molecular deletion and rearrangement of a locus at 13q14, distinct from retinoblastoma (Rb1) locus, was found. In this unusual case, the PML/RARalpha product seems to be not essential for the expression of the promyelocytic phenotype at diagnosis and, when detectable, it is not the sole genetic defect.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10867147 DOI: 10.1016/s0165-4608(99)00233-2
Source DB: PubMed Journal: Cancer Genet Cytogenet ISSN: 0165-4608